# Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

> **NCT01169870** · PHASE2 · WITHDRAWN · sponsor: **National Cancer Center, Korea**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Genexol-PM
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01169870
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-07
- **Primary completion:** 2008-08
- **Final completion:** 2008-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn studies
- **Last updated:** 2012-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169870, "Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01169870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*